Acasti Pharma Inc. (ACST) |
|---|
| $1.11 52 Week Low | $1.28 2017-04-28 14:01:34 MDT | $3.09 52 Week High |
| Healthcare Sector | Biotechnology Industry |
| Nasdaq Stock Exchange | Canada Country |
| Market Cap: | $18,720,000 | Micro Cap (Less than $200M) |
| Analyst Recommendation: | 2 | Analysts say: Buy. (1=Strong Buy, 5=Strong Sell) |
| Beta: | 1.09 | Higher Volatility Stock (beta over 1). Stock will go up more when the market goes up, and go down more when the market goes down. Beta of 1 means stock would match the S&P 500 Index. |
ForwardPE: Unknown | 5 Yr Est Growth: Unknown | Yield: 0.00% |
PEG-Y Ratio: N/A | Unknown PEG-Y ratio |
% Above 50 DayMA: 0.00% | % Above 200 DayMA: 0.00% |
ACST Performance 52 Weeks: 0.00% | S&P 500 Performance 52 Weeks: 0.00% |
Uptrend is still intact: ACST is above both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week Low than 52 Week High. | ACST outperforming S&P 500 by 0.00% the last 52 Weeks. |
Price To Book: N/A | Unknown Price to Book Ratio |
EV to EBITDA: N/A | Unknown EV to EBITDA ratio |
| Field | Value | Average | Comments |
|---|---|---|---|
| % Held By Insiders | N/A | 17.28% | Unknown. |
| % Held By Institutions | N/A | 62.07% | Unknown. |
| Short % Of Float | N/A | 07.02% | Unknown. |
| Debt to Equity | N/A | 1.08 | Unknown. |
| Profit Margin % | N/A | -00.18% | Unknown. |
| Operating Margin % | N/A | -05.28% | Unknown. |
| Return on Equity % | N/A | -08.79% | Unknown. |
| Return on Assets % | N/A | -01.29% | Unknown. |
| Revenue Per Employee | $N/A | $883,096.70 | Unknown. |
| Price to Cash | N/A | 5.52 | Unknown. |
| CPEGY Ratio | N/A | 2.26 | Unknown. |
PROS:
| CONS: |